Perkins Capital Management’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-600
| Closed | -$3K | – | 96 |
|
|
2023
Q3 | $3K | Sell |
600
-220
| -27% | -$1.1K | ﹤0.01% | 98 |
|
|
2023
Q2 | $10K | Sell |
820
-80
| -9% | -$976 | 0.01% | 95 |
|
|
2023
Q1 | $8K | Sell |
900
-1,180
| -57% | -$10.5K | 0.01% | 95 |
|
|
2022
Q4 | $21K | Sell |
2,080
-180
| -8% | -$1.82K | 0.02% | 97 |
|
|
2022
Q3 | $37K | Sell |
2,260
-4,292
| -66% | -$70.3K | 0.04% | 97 |
|
|
2022
Q2 | $211K | Buy |
6,552
+550
| +9% | +$17.7K | 0.22% | 80 |
|
|
2022
Q1 | $402K | Buy |
6,002
+560
| +10% | +$37.5K | 0.33% | 73 |
|
|
2021
Q4 | $306K | Sell |
5,442
-418
| -7% | -$23.5K | 0.21% | 83 |
|
|
2021
Q3 | $592K | Sell |
5,860
-640
| -10% | -$64.7K | 0.37% | 65 |
|
|
2021
Q2 | $804K | Buy |
+6,500
| New | +$804K | 0.46% | 58 |
|
|
2021
Q1 | – | Sell |
-800
| Closed | -$118K | – | 111 |
|
|
2020
Q4 | $118K | Buy |
+800
| New | +$118K | 0.08% | 91 |
|